Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958191 · ClinicalTrials.gov registry record · NA
Trident® X3 Polyethylene Insert Study
A NA study, sponsored by Stryker Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT00958191 is a NA study that has completed, run by Stryker Orthopaedics. The registered enrollment target is 250 participants.
The verdict
NCT00958191, a NA study, has completed, sponsored by Stryker Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
The primary objective of the study is to demonstrate the linear wear rates of the Trident® X3 polyethylene insert are superior to a polyethylene control group wear rate at 5 years postoperative. This measurement will be evaluated by comparing digitized images of serial radiographs obtained over a follow-up period of 5-years.
Interventions
- DEVICE Trident® X3 Polyethylene Insert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2005-05 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00958191
The ClinicalTrials.gov registry entry for NCT00958191 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trident® X3 Polyethylene Insert is the first listed.
NCT00958191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00958191 about?
NCT00958191 is a clinical study titled "Trident® X3 Polyethylene Insert Study". The primary objective of the study is to demonstrate the linear wear rates of the Trident® X3 polyethylene insert are superior to a polyethylene control group wear rate at 5 years postoperative. This measurement will be evaluated by comparing digitized images of serial radiographs obtained over a fo...
What is the current status of trial NCT00958191?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2005-05. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00958191?
The interventions under investigation include: Trident® X3 Polyethylene Insert (DEVICE).
Who is sponsoring clinical trial NCT00958191?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.